Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Hims & Hers Health, Inc.'s share price surged when a global shortage of tirzepatide / semaglutide - a rival ... platform for $349 per month at the 2.5mg dose, and $499 at the 5mg dose, while ...

The company has introduced the drug in two strengths—2.5 mg vials priced at Rs ... working on generic versions of semaglutide, which is marketed in the US under the brand names Ozempic and ...

Semaglutide is a type of medication originally developed to treat type 2 diabetes. It works by mimicking a natural hormone in the body called glucagon-like peptide ... at the 0.5 mg weekly dose ...

The studies suggest that glucagon-like peptide-1 (GLP ... recently launched by US Pharma major Eli Lilly through select pharmacies and hospitals. The drug is available by prescription only. It is ...

It mimics two hormones, glucagon-like peptide-1 (GLP-1) and the glucose-dependent insulinotropic polypeptide (GIP), to lower blood sugar and promote weight loss. In contrast, semaglutide works ... the ...

As newer medications gained prominence, I prescribed Semaglutide (RYBELSUS®), an oral GLP-1 receptor agonist, to aid in weight management. GLP-1 (glucagon-like peptide-1 ... from overseas and started ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic ® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the US.